The present study also identifies a positive correlation between the plasma concentrations of thrombomodulin and PAI-1 and fibrinogen, suggesting that the plasma concentration of thrombomodulin represents hypercoagulability in diabetic patients. Here, THBD is linked to thrombophilia.